Peter E. Coremans

Vitaz Sint Niklaas Moerland
Sint Niklaas, BE 
Vitaz Sint Niklaas Moerland
Sint Niklaas, BE 

Overview

Peter Coremans practices practicing medicine in Sint Niklaas, Belgium.

His clinical expertise encompasses Sertoli Cell-Only Syndrome, Ectopic Cushing's syndrome, Hypopituitarism, Maturity Onset Diabetes of the Young, and Orchiectomy.

He is actively involved in clinical research, co-authoring 12 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Vitaz Sint Niklaas Moerland
Sint Niklaas, Belgium
Other Locations
AZ Jan Portaels
Vilvoorde, VLG, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
Enrollment Status: Completed
Publish Date: July 08, 2026
Intervention Type: Drug
Study Drugs: Tirzepatide, Dulaglutide
Study Phase: Phase 3
A Randomized, Phase 3, Open-label Trial Comparing the Effect of the Addition of Tirzepatide Once Weekly Versus Insulin Lispro (U100) Three Times Daily in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin (SURPASS-6)
A Randomized, Phase 3, Open-label Trial Comparing the Effect of the Addition of Tirzepatide Once Weekly Versus Insulin Lispro (U100) Three Times Daily in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin (SURPASS-6)
Enrollment Status: Completed
Publish Date: November 02, 2023
Intervention Type: Drug
Study Drugs: Tirzepatide, Insulin Lispro, Insulin Glargine
Study Phase: Phase 3
View 1 Less Clinical Trial

12 Total Publications

Semaglutide for prevention of type 2 diabetes in women with postpartum prediabetes after gestational diabetes: protocol for a Belgian multicentre double-blind randomised placebo-controlled trial.
Semaglutide for prevention of type 2 diabetes in women with postpartum prediabetes after gestational diabetes: protocol for a Belgian multicentre double-blind randomised placebo-controlled trial.
Journal: BMJ open
Published: July 23, 2026

Frequently Asked Questions about Peter E. Coremans

Is Peter E. Coremans a top-rated expert for Sertoli Cell-Only Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Peter E. Coremans is classified as an Experienced expert for Sertoli Cell-Only Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Peter E. Coremans participate in research or clinical trials?

Yes. Peter E. Coremans has published 12 articles and abstracts on conditions like Sertoli Cell-Only Syndrome. You can view a list of Peter E. Coremans's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Coremans's expertise for a condition
ConditionClose
        View All 17 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile